Made an attempt 4 months ago for 30/200 cross
this time it will be a breeze
Fundamentals
it recieved orphan drug status
3 months ago...
new patents approved...
Large gov't grant for phase2 cancer trials...
Market cap. easily affordable for an acquirer...
Technically it is ready for uptrend to begin.